Is Inducible Nitric Oxide Synthase a Target for Chemoprevention?

The molecular messenger nitric oxide (NO) is synthesized endogenously from l -arginine by three isoforms of the enzyme NO synthase. The isoform most consistently associated with neoplasia is the inducible form, inducible nitric oxide synthase (iNOS). However, the role played by the NO/iNOS system in...

Full description

Saved in:

Bibliographic Details
Published in:	Molecular cancer therapeutics Vol. 2; no. 8; p. 815
Main Authors:	Crowell, James A, Steele, Vernon E, Sigman, Caroline C, Fay, Judith R
Format:	Journal Article
Language:	English
Published:	United States American Association for Cancer Research 01-08-2003
Subjects:	Animals Chemoprevention Nitric Oxide Synthase - physiology Nitric Oxide Synthase Type II
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The molecular messenger nitric oxide (NO) is synthesized endogenously from l -arginine by three isoforms of the enzyme NO synthase. The isoform most consistently associated with neoplasia is the inducible form, inducible nitric oxide synthase (iNOS). However, the role played by the NO/iNOS system in tumor development is complex, and both promoting and inhibitory effects on neoplasia have been reported. This review attempts to clarify the role of iNOS in carcinogenesis, with particular emphasis on the early stages of tumor development, offers possible explanations for the confused picture presented in the literature regarding the association of the NO/iNOS pathway with neoplasia, and identifies selective iNOS inhibitors that may have chemopreventive potential.
ISSN:	1535-7163 1538-8514